Blog

Oct 2, 2024, 13:33

JAMA Oncology – IMRT shows improved safety for locally advanced NSCLC

JAMA Oncology shared on X:

”Improvements in radiation using IMRT translated into less pneumonitis for locally-advanced NSCLC in NRG Oncology-RTOG 0617 compared to 3D-CRT. Planning should minimize the heart V40Gy and lung V20Gy, as the lung V5Gy had no long-term impact on outcome.”

Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer.

Authors: Stephen G. Chun, Chen Hu, Ritsuko U. Komaki, Robert D. Timmerman, Steven E. Schild, Jeffrey A. Bogart, Michael C. Dobelbower, Walter Bosch, Vivek S. Kavadi, Samir Narayan, Puneeth Iyengar, Clifford Robinson, Jan Rothman, Adam Raben, Mark E. Augspurger, Robert M. MacRae, Rebecca Paulus, Jeffrey D. Bradley.

JAMA Oncology - IMRT shows improved safety for locally advanced NSCLC

Source: JAMA Oncology/X

Adam Raben cancer Chen Hu Clifford Robinson IMRT JAMA Oncology Jan Rothman Jeffrey A. Bogart Jeffrey D. Bradley Mark E. Augspurger Michael C. Dobelbower NRG Oncology OncoDaily Oncology Puneeth Iyengar Rebecca Paulus Ritsuko U. Komaki Robert D. Timmerman Robert M. MacRae Samir Narayan Stephen G. Chun Steven E. Schild Vivek S. Kavadi Walter Bosch

FDA Approves T-DXd for HR+, HER2-Low/Ultralow Breast Cancer Treatment

Oncologist Near Me - Hagop Kantarjian: A Legend in Leukemia Research and Treatment

New Paper Alert: Botensilimab and Balstilimab in Relapsed/Refractory Metastatic Sarcomas

Best of ASCOGI25

Egypt Cancer Society (ECS) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care